期刊
CYTOKINE & GROWTH FACTOR REVIEWS
卷 25, 期 4, 页码 437-442出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2014.07.010
关键词
IL-13Ra2; IL-4R antagonist; CD8 T cell avidity; Vaccines; Infection and immunity
资金
- Australian National Health and Medical Research Council [525431]
- Bill and Melinda Gates Foundation GCE Phase I grant
- EOI grants [ACH2]
- [APP1000703]
The roles of interleukin (IL)-4 and IL-13 during both innate and adaptive Th2 mediated immunity have received considerable scrutiny, however, mechanisms by which these cytokines influence the cellular interactions involved in negatively modulating the development of effective Th1 immunity are poorly characterized. In this article we discuss the recent advances in IL-4/IL-13 biology, mainly (i) role of these cytokines in allergic inflammation, atopic dermatitis, cancer, transplant rejection, bacterial/viral infections, and specifically the therapeutic potential of IL-13R alpha 2, (ii) insights into how alarmin stimulation activate IL-4/IL-13 at the lung mucosae, (iii) how these two cytokines modulate antigen-specific CD8(+) T cell quality/avidity in a vaccine route dependent manner and (iv) finally discuss the potential of using transient inhibition of IL-4 and/or IL-13 at the vaccination site as a platform vaccine technology to induce strong sustained high quality CD8(+) T cell immunity for protection against many chronic mucosal pathogens such as HIV-1. (C) 2014 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据